DK1638598T3 - Akapsulære P. multocida hyaE-deletionsmutanter - Google Patents

Akapsulære P. multocida hyaE-deletionsmutanter

Info

Publication number
DK1638598T3
DK1638598T3 DK04777430T DK04777430T DK1638598T3 DK 1638598 T3 DK1638598 T3 DK 1638598T3 DK 04777430 T DK04777430 T DK 04777430T DK 04777430 T DK04777430 T DK 04777430T DK 1638598 T3 DK1638598 T3 DK 1638598T3
Authority
DK
Denmark
Prior art keywords
acapsular
multocida
deletion mutants
hyae deletion
birds
Prior art date
Application number
DK04777430T
Other languages
English (en)
Inventor
Robert E Briggs
Fred M Tatum
Original Assignee
Biotechnology Res & Dev
Us Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Res & Dev, Us Agriculture filed Critical Biotechnology Res & Dev
Application granted granted Critical
Publication of DK1638598T3 publication Critical patent/DK1638598T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
DK04777430T 2003-07-02 2004-07-02 Akapsulære P. multocida hyaE-deletionsmutanter DK1638598T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60893103P 2003-07-02 2003-07-02
PCT/US2004/021274 WO2005003330A2 (en) 2003-07-02 2004-07-02 Acapsular p. multocida hyae deletion mutants

Publications (1)

Publication Number Publication Date
DK1638598T3 true DK1638598T3 (da) 2007-03-26

Family

ID=33564219

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04777430T DK1638598T3 (da) 2003-07-02 2004-07-02 Akapsulære P. multocida hyaE-deletionsmutanter

Country Status (20)

Country Link
US (1) US7351416B2 (da)
EP (1) EP1638598B1 (da)
JP (2) JP5001647B2 (da)
KR (1) KR101119216B1 (da)
CN (1) CN1798574B (da)
AT (1) ATE347373T1 (da)
AU (1) AU2004254619B2 (da)
BR (1) BRPI0410911B1 (da)
CA (1) CA2530779C (da)
DE (1) DE602004003582T2 (da)
DK (1) DK1638598T3 (da)
ES (1) ES2278344T3 (da)
HK (1) HK1088561A1 (da)
HR (1) HRP20070084T3 (da)
NZ (1) NZ543771A (da)
PL (1) PL1638598T3 (da)
PT (1) PT1638598E (da)
SI (1) SI1638598T1 (da)
WO (1) WO2005003330A2 (da)
ZA (1) ZA200509533B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080241192A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
ES2612252T3 (es) * 2008-11-10 2017-05-16 Novo Nordisk A/S Cepa de E. coli BL21 que carece de un complejo génico funcional de los genes capsulares del grupo II
US9115547B2 (en) * 2009-06-22 2015-08-25 Frank's International, Llc Large diameter tubular lifting apparatuses and methods
EP2445969B1 (en) 2009-06-26 2014-08-27 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Novel fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
CA2890466C (en) 2012-11-08 2022-07-19 Merial, Inc. Attenuated mannheimia haemolytica vaccines and methods of making and use
US20140147475A1 (en) * 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
US9480739B2 (en) 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
US9393298B2 (en) 2013-03-15 2016-07-19 Intervet Inc. Liquid stable bovine virus vaccines
WO2014147001A1 (en) 2013-03-18 2014-09-25 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
ES2824402T3 (es) * 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
AR099470A1 (es) 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
TWI670085B (zh) 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
MX2017002803A (es) 2014-09-03 2017-06-09 Intervet Int Bv Coronavirus bovino atenuado y vacunas relacionadas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
US20010018055A1 (en) * 1997-09-25 2001-08-30 Briggs Robert E. Deletion mutants of virulence factors of pasteurellaceae
IL158007A0 (en) * 2001-03-23 2004-03-28 S2 Technologies Inc Development and testing system and method
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US7449178B2 (en) 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
EP1350796B1 (en) * 2002-04-05 2009-01-07 Merial Attenuated gram negative bacteria

Also Published As

Publication number Publication date
BRPI0410911A (pt) 2006-06-27
JP2007524398A (ja) 2007-08-30
AU2004254619B2 (en) 2009-05-21
DE602004003582D1 (de) 2007-01-18
EP1638598B1 (en) 2006-12-06
CN1798574A (zh) 2006-07-05
JP2011024587A (ja) 2011-02-10
KR20060020657A (ko) 2006-03-06
PL1638598T3 (pl) 2007-05-31
WO2005003330A2 (en) 2005-01-13
EP1638598A2 (en) 2006-03-29
KR101119216B1 (ko) 2013-03-18
AU2004254619A1 (en) 2005-01-13
CN1798574B (zh) 2013-12-11
ZA200509533B (en) 2007-03-28
PT1638598E (pt) 2007-03-30
SI1638598T1 (sl) 2007-04-30
US20050106185A1 (en) 2005-05-19
HK1088561A1 (en) 2006-12-08
NZ543771A (en) 2008-05-30
DE602004003582T2 (de) 2007-09-20
HRP20070084T3 (en) 2008-09-30
BRPI0410911B1 (pt) 2014-07-08
WO2005003330A3 (en) 2005-03-03
CA2530779C (en) 2012-06-05
ATE347373T1 (de) 2006-12-15
ES2278344T3 (es) 2007-08-01
US7351416B2 (en) 2008-04-01
JP5649881B2 (ja) 2015-01-07
JP5001647B2 (ja) 2012-08-15
CA2530779A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
HK1088561A1 (en) Acapsular i p. multocida hyae /I. deletion mutants
McDermott et al. Interleukin‐23 (IL‐23), independent of IL‐17 and IL‐22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice
AR076613A1 (es) Alimento para mascotas en forma de alimento granulado recubierto
NO971051D0 (no) Middel for å öke produksjonen av oppdretts- og produksjonsdyr i fjærfeindustrien
ATE336998T1 (de) Antioxidative zusammensetzungen für haustiere
BRPI0510930A (pt) vacinas de subunidade de prrsv
BR0316700A (pt) previsão da performance animal
Murphy et al. Pig‐shed air polluted by α‐haemolytic cocci and ammonia causes subclinical disease and production losses
Rinaldi et al. Immunologically based control strategies for ostertagiosis in cattle: where do we stand?
Torre et al. Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice
NO20040354L (no) Fremgangsmater og sammensetninger for kontroll av koksidose
ATE336177T1 (de) Hypoallergene diätetische zusammensetzung für haustiere.
FI20021518A0 (fi) Avidiinin lämpökestävyyden lisääminen
WO2003096799A3 (en) Multiple closed nucleus breeding for swine production
BRPI0506699A (pt) método para lavar aves domésticas durante o processamento com composições de ácido peroxicarboxìlicos de cadeias médias
RU2009101018A (ru) Индукция толерантности к белкам яиц
Raseta et al. Contamination Routes of S. Infantis in food chain of broiler meat production and it's significance for public health
DK1322151T3 (da) Fremgangsmåde til frembringelse af ikke-humane pattedyr
Gray et al. Interferon‐γ and nitric oxide production are not required for the immune‐mediated clearance of Brugia malayi microfilariae in mice
BR0115310A (pt) Ração
MXPA05012219A (es) Vacuna aviar combinada contra e. coli y salmonella.
DE60008215D1 (de) Freies tyrosin enthaltendes futter oder veterinäre zusammensetzung für fleischfressende haustiere
AU2003274925A8 (en) Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
MXPA05009489A (es) Procedimientos para identificacion de atributos geneticos en animales.
SE9800505L (sv) Probiotisk komposition innehållande sporer från jästarten Endomyces fibuliger och användning därav